Skip to main content
Skip to main content
VHIBF logo

Vitalhub Corp. (VHIBF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$5.40 -$0.07 (-1.28%) |CouncilBullish Lean · 65 · B+
MCap: $342M| P/E Ratio: 63.41| Vol: 200|

P/E 63.41 means the share price is 63.41 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $342M is the value of all shares combined. Beta 0.77: the stock has moved about 23% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Vitalhub Corp. (VHIBF) trades at $5.40. Vitalhub Corp. (VHIBF) is a Toronto-based healthcare technology company specializing in digital solutions for health and human services sectors. Market cap: $342M, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026
Vitalhub Corp. (VHIBF) is a Toronto-based healthcare technology company specializing in digital solutions for health and human services sectors. Established in 2010, it offers a diverse software portfolio aimed at enhancing operational efficiency and patient care coordination across multiple countries.

Analyst Coverage for VHIBF: VHIBF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VHIBF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the VHIBF film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 65/100 · B+

VHIBF: 1/2 scored disciplines lean bullish. Dominant signal: Ken Griffin bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Vitalhub Corp. (VHIBF) Healthcare & Pipeline Overview

CEODaniel Paul Matlow
Employees700
HeadquartersToronto, CA
IPO Year2021

Vitalhub Corp. (VHIBF) delivers innovative digital solutions tailored for healthcare providers, focusing on electronic health records, case management, and operational efficiency, thereby enhancing patient care and organizational performance in a rapidly evolving healthcare landscape.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for VHIBF?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Vitalhub Corp. operates in a growing market for healthcare technology, with a market cap of $342M and a P/E ratio of 63.41, indicating investor confidence in its growth potential. The company’s gross margin of 74.8% reflects its efficient operational model, while a profit margin of 6.1% suggests room for improvement in profitability. Key growth catalysts for Vitalhub include the increasing global demand for digital health solutions, expansion into new geographic markets, and the continuous enhancement of its software offerings. The healthcare technology sector is projected to grow significantly, driven by the need for improved patient care and operational efficiencies. However, potential risks include the challenges associated with being listed on the OTC Other tier, which may affect liquidity and investor confidence. Vitalhub's ability to secure larger contracts and scale its operations will be crucial for its sustained growth.

Based on FMP financials and quantitative analysis

VHIBF Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market cap of $342M reflects strong investor interest in healthcare technology.

  • P/E ratio of 63.41 indicates high growth expectations relative to earnings.
  • Gross margin of 74.8% demonstrates operational efficiency and strong pricing power.
  • Profit margin of 6.1% suggests potential for profitability improvement.
  • Beta of 0.77 indicates lower volatility compared to the broader market.

Who Are VHIBF's Competitors?

VHIBF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CERN Cerner Corporation $94.92 0.00%
MCK McKesson Corporation $887.01 -0.52% $104B 885-pillar
ATHN Athena Technology Acquisition Corp. $9.59 -0.52% $1.84B
HCA HCA Healthcare, Inc. $421.21 -0.15% $91.2B 815-pillar
SY So-Young International Inc. $2.62 -2.24% $344M 345-pillar
SLP Simulations Plus, Inc. $18.43 +0.03% $373M 805-pillar
CARL CARLSMED, INC. $14.76 -1.53% $401M 315-pillar
EVH Evolent Health, Inc $4.17 +0.48% $469M

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VHIBF's Key Strengths?

Robust software portfolio tailored for healthcare needs.

  • Strong presence in multiple international markets.
  • High gross margins indicating operational efficiency.
  • Established relationships with healthcare organizations.

What Are VHIBF's Weaknesses?

Limited brand recognition compared to larger competitors.

  • Dependence on a few key markets for revenue.
  • Challenges associated with being listed on the OTC market.
  • Potential for slower growth in saturated markets.

What Could Drive VHIBF Stock Higher?

Expansion into new geographic markets, particularly in Western Asia and Africa.

  • Development of new features for electronic health records and patient management.
  • Strategic partnerships with healthcare providers to enhance service offerings.
  • Increased demand for telehealth solutions post-pandemic.
  • Government initiatives supporting digital health solutions.

What Are the Key Risks for VHIBF?

Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.

  • Rich valuation — a P/E of 63.41 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.
  • Intense competition from larger healthcare technology firms.
  • Challenges associated with being listed on the OTC market.
  • Regulatory changes impacting the healthcare technology sector.
  • Economic downturns affecting healthcare spending.

What Are the Growth Opportunities for VHIBF?

  • Expansion into New Markets: Vitalhub has the opportunity to expand its presence in emerging markets, particularly in Western Asia and Africa, where the demand for digital health solutions is on the rise. The global healthcare IT market is expected to grow at a CAGR of 15%, providing a substantial opportunity for Vitalhub to capture new clients and increase revenues over the next five years.
  • Enhancement of Product Offerings: The continuous development of Vitalhub's software portfolio, including advanced features for electronic health records and patient management, presents a significant growth opportunity. As healthcare organizations increasingly seek integrated solutions to improve operational efficiency, Vitalhub can leverage its expertise to enhance its offerings and attract new customers.
  • Partnerships and Collaborations: Forming strategic partnerships with healthcare providers and technology firms can accelerate Vitalhub's growth. Collaborations can lead to joint ventures that enhance product development and market reach, particularly in regions where Vitalhub aims to expand its footprint. This could significantly boost revenue streams over the next few years.
  • Increased Demand for Telehealth Solutions: The COVID-19 pandemic has accelerated the adoption of telehealth services, creating a growing market for digital health solutions. Vitalhub can capitalize on this trend by enhancing its offerings to include telehealth functionalities, thereby attracting healthcare providers looking to improve patient engagement and care delivery.
  • Regulatory Support for Digital Health: Governments worldwide are increasingly supporting digital health initiatives through funding and favorable regulations. Vitalhub can leverage this environment to secure contracts with public health organizations, enhancing its revenue potential and market presence in the healthcare technology sector.

What Are VHIBF's Competitive Advantages?

  • Strong reputation for delivering high-quality digital health solutions.
  • Diverse software portfolio addressing various aspects of healthcare management.
  • Established relationships with key stakeholders in the healthcare industry.
  • Ability to innovate and adapt to changing market needs.
  • Expertise in integrated care coordination, setting it apart from competitors.

What Does VHIBF Do?

Vitalhub Corp. was founded in 2010 and is headquartered in Toronto, Canada. The company operates through its subsidiaries, providing advanced digital solutions specifically designed for organizations within the health and human services sectors. Vitalhub has established a significant global presence, with its solutions deployed in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse software portfolio includes electronic health record systems, robust case management tools, integrated care coordination platforms, and various mobile applications aimed at optimizing patient flow and enhancing operational oversight. Over the years, Vitalhub has evolved to meet the increasing demand for digital health solutions, positioning itself as a key player in the healthcare technology market. The company's offerings are designed to improve efficiency and coordination within healthcare organizations, addressing the growing need for effective patient management and operational transparency. Vitalhub's commitment to innovation and quality has enabled it to build a strong reputation in the healthcare sector, making it a trusted partner for healthcare providers seeking to enhance their service delivery and operational capabilities.

What Products and Services Does VHIBF Offer?

  • Provide electronic health record systems for healthcare organizations.
  • Develop case management tools to streamline patient care processes.
  • Offer integrated care coordination platforms for improved healthcare delivery.
  • Create mobile applications to enhance patient engagement and access to services.
  • Optimize patient flow and operational oversight through advanced software solutions.
  • Deliver customized digital solutions tailored to the needs of health and human services sectors.

How Does VHIBF Make Money?

  • Generate revenue through software licensing and subscription fees.
  • Offer consulting services to healthcare organizations for system implementation.
  • Provide ongoing support and maintenance for software solutions.
  • Develop custom software solutions tailored to specific client needs.
  • Engage in partnerships with healthcare providers to enhance service offerings.

What Industry Does VHIBF Operate In?

The healthcare technology industry is experiencing rapid growth, driven by the increasing demand for digital solutions that enhance patient care and operational efficiency. Vitalhub Corp. is well-positioned within this landscape, offering a range of solutions that address critical needs in electronic health records and care coordination. The competitive landscape includes established players and emerging startups, making innovation and adaptability key factors for success. Vitalhub's focus on integrated solutions allows it to differentiate itself in a crowded market.

Who Are VHIBF's Key Customers?

  • Healthcare providers including hospitals and clinics.
  • Government health agencies and public health organizations.
  • Non-profit organizations focused on health and human services.
  • Private sector companies in the healthcare technology space.
  • International healthcare organizations seeking digital solutions.
Model self-rating on this text: 71% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

Medium 45/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 73 days ago
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 63
2026-08-26 63
2026-08-29 63
2026-09-01 63
2026-09-04 63
2026-09-07 63
2026-09-10 63

What changed?

The score has stayed at 63.

Over the same 18 days the stock moved -5.7%.

Vitalhub Corp. (VHIBF) Valuation Context

Valued at $342M, VHIBF is classified as a small-cap stock.

VHIBF Revenue & Earnings Trend

In Q2 FY2026, VHIBF generated $31.7M in top-line revenue, marking a sequential decrease of 0.8%. The company recorded net income of $1.9M, with diluted EPS of $0.03. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, VHIBF averaged $0.03 in diluted EPS.

Company Profile

Vitalhub Corp. operates in the Health Information Services industry within the Healthcare sector. It is headquartered in Toronto, Canada.

ROE 3%

Key Financial Metrics

Return on equity for Vitalhub Corp. stands at 2.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.0%, showing how much profit it generates from its asset base. VHIBF trades at a trailing price-to-earnings ratio of 63.41, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 4.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.15 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.6%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 5/9

Financial Health

Vitalhub Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.45 places it in the safe zone, indicating low near-term bankruptcy risk.

1/8 beats

Earnings Track Record

Vitalhub Corp. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 34.1% below estimates on average.

VHIBF Financials

Fundamental Snapshot

Revenue Growth (FY)
+58.7%
Net Income Growth (FY)
+103.6%
EPS Growth (FY)
+63.9%
Free Cash Flow Growth (FY)
-44.6%
P/E (TTM)
63.41
Return on Equity (TTM)
+2.8%
Current Ratio
2.2
EV/EBITDA (TTM)
15.4

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Robust software portfolio tailored for healthcare needs.
  • Strong presence in multiple international markets.
  • High gross margins indicating operational efficiency.
  • Established relationships with healthcare organizations.

Bear Case

  • Limited brand recognition compared to larger competitors.
  • Dependence on a few key markets for revenue.
  • Challenges associated with being listed on the OTC market.
  • Potential for slower growth in saturated markets.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 C$32M C$2M C$0.03
Q1 FY2026 C$32M C$2M C$0.04
Q4 FY2025 C$31M C$4M C$0.06
Q3 FY2025 C$32M -C$890,260 -C$0.01

Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep

Based on FMP financials and quantitative analysis · Reported in CAD

VHIBF Latest News

VHIBF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for VHIBF.

Price Targets

Wall Street price target analysis for VHIBF.

VHIBF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for VHIBF; grades run from A+ (80-100) to F (below 30).

Leadership: Daniel Paul Matlow

CEO

Daniel Paul Matlow has extensive experience in the healthcare technology sector, having led Vitalhub Corp. since its inception in 2010. He holds a degree in Computer Science and has previously held leadership roles in various technology firms. His expertise lies in developing innovative solutions that address the needs of healthcare organizations, making him a key figure in the company's growth and strategic direction.

Track Record: Under Matlow's leadership, Vitalhub has expanded its product offerings and established a significant presence in international markets. His strategic decisions have led to increased revenue and improved operational efficiency, positioning the company for future growth.

VHIBF OTC Market Information

The OTC Other tier represents stocks that trade on the over-the-counter market but do not meet the stringent requirements of major exchanges like NYSE or NASDAQ. This tier often includes smaller companies, which can lead to lower visibility and liquidity compared to stocks listed on major exchanges.

  • OTC Tier: OTC Other
Liquidity: Trading volume for OTC stocks like VHIBF can be lower than that of stocks on major exchanges, leading to wider bid-ask spreads and potential difficulties in executing trades. Investors should be aware of these liquidity concerns when considering investments.
OTC Risk Factors:
  • Lower liquidity compared to stocks listed on major exchanges.
  • Higher volatility due to smaller market capitalization.
  • Limited access to financial information and disclosures.
  • Potential for less regulatory oversight.
Due Diligence Checklist:
  • Verify the company's financial health through available reports.
  • Assess the competitive landscape and market position.
  • Understand the risks associated with OTC investments.
  • Evaluate the management team's track record and experience.
  • Monitor industry trends and growth potential.
Legitimacy Signals:
  • Established presence in multiple international markets.
  • Strong product portfolio addressing healthcare needs.
  • Positive reputation among existing customers and partners.

What Investors Ask About Vitalhub Corp. (VHIBF) — Healthcare

Is VHIBF a good stock?

Stock Expert AI does not rate VHIBF buy, sell or hold. Vitalhub Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the main risks for VHIBF?

Vitalhub Corp. faces several risks, including intense competition from larger healthcare technology firms that could impact market share. Being listed on the OTC market presents challenges such as lower liquidity and higher volatility.

What are the key factors to evaluate for VHIBF?

Evaluate VHIBF on fundamentals, analyst consensus, and risk factors. P/E: 63.41x vs the S&P 500's ~20-25x. Vitalhub Corp. operates in a growing market for healthcare technology, with a market cap of $342M and a P/E ratio of 63.41, indicating investor confidence in its growth potential. Not financial advice.

How frequently does VHIBF data refresh on this page?

VHIBF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven VHIBF's recent stock price performance?

Vitalhub Corp. (VHIBF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Robust software portfolio tailored for healthcare needs. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider VHIBF overvalued or undervalued right now?

Vitalhub Corp. (VHIBF) trades at 63.41x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of VHIBF?

Yes, most major brokerages offer fractional shares of Vitalhub Corp. (VHIBF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track VHIBF's earnings and financial reports?

Vitalhub Corp. (VHIBF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for VHIBF earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on available financial metrics and company information.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover